Siemens Healthineers AG
XETRA:SHL
Intrinsic Value
Siemens Healthineers AG operates as a holding company. [ Read More ]
The intrinsic value of one
SHL
stock under the Base Case scenario is
65.88
EUR.
Compared to the current market price of 50.8 EUR,
Siemens Healthineers AG
is
Undervalued by 23%.
Siemens Healthineers AG's market capitalization is 56.7B EUR.
SHL stock price is 50.8 EUR.
SHL stock price (50.8 EUR) is 23% less than its Intrinsic Value (65.88 EUR).
SHL has upside potential of 19% compared to the average analyst price target.
Open Wall St Estimates
SHL's Revenue has grown by 0% over the past 12 months.
SHL has positive Net Income for the last twelve months.
SHL's ROE (Return on Equity) for the past 12 months is positive and is equal to 8%.
SHL has positive three-year average ROE (Return on Equity): 11%. The company is efficient at transforming stockholders' equity into net income.
SHL's ROIC (Return on Invested Capital) has decreased in the last 3 years from 6% to 4%.
SHL's short-term assets (14B EUR) exceed its short-term liabilties (12B EUR).
SHL has positive Operating Income for the last twelve months.
SHL's Revenue is forecast to grow at a rate of 7% per year over the next 3 years.
SHL's ROE (Return on Equity) has decreased in the last 3 years from 13% to 8%.
SHL's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 4%.
SHL's Revenue has been growing by 14% per year for the last 3 years.
SHL has positive three-year average ROIC (Return on Invested Capital): 5%. The company is efficient at using invested capital to generate operating income.
SHL has positive Free Cash Flow for the last twelve months.
SHL's long-term assets (46B EUR) exceed its long-term liabilties (28B EUR).
SHL has positive Gross Profit for the last twelve months.
SHL's D/E (Debt to Equity) is very low and is equal to 0.69.
SHL's Altman Z-Score is equal to 1.95.
SHL has positive Net Debt. This means that the company has more debt (12B EUR) than cash and short-term investments (2B EUR).
SHL generates enough operating income (2B EUR) to cover interest payments on its debt (342m EUR).
Valuation Backtest
Siemens Healthineers AG
Run backtest to discover the historical profit from buying and selling
SHL
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Siemens Healthineers AG
Balance Sheet Decomposition
Siemens Healthineers AG
| Current Assets | 13.8B |
| Cash & Short-Term Investments | 2B |
| Receivables | 6.7B |
| Other Current Assets | 5.2B |
| Non-Current Assets | 31.7B |
| Long-Term Investments | 1.4B |
| PP&E | 4.2B |
| Intangibles | 25.2B |
| Other Non-Current Assets | 959m |
| Current Liabilities | 12.4B |
| Accounts Payable | 2.1B |
| Other Current Liabilities | 10.3B |
| Non-Current Liabilities | 15.3B |
| Long-Term Debt | 12.3B |
| Other Non-Current Liabilities | 3B |
Earnings Waterfall
Siemens Healthineers AG
|
Revenue
|
21.8B
EUR
|
|
Cost of Revenue
|
-14B
EUR
|
|
Gross Profit
|
7.8B
EUR
|
|
Operating Expenses
|
-5.6B
EUR
|
|
Operating Income
|
2.2B
EUR
|
|
Other Expenses
|
-689m
EUR
|
|
Net Income
|
1.5B
EUR
|
Free Cash Flow Analysis
Siemens Healthineers AG
What is Free Cash Flow?
SHL Profitability Score
Profitability Due Diligence
Siemens Healthineers AG's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
Siemens Healthineers AG's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
SHL Solvency Score
Solvency Due Diligence
Siemens Healthineers AG's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Siemens Healthineers AG's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SHL Price Targets Summary
Siemens Healthineers AG
According to Wall Street analysts, the average 1-year price target for
SHL
is 60.28 EUR
with a low forecast of 48.48 EUR and a high forecast of 69.83 EUR.
Shareholder Return
SHL Price
Siemens Healthineers AG
| Average Annual Return | 11.01% |
| Standard Deviation of Annual Returns | 36.03% |
| Max Drawdown | -38% |
| Market Capitalization | 56.7B EUR |
| Shares Outstanding | 1 115 788 114 |
| Percentage of Shares Shorted |
N/A
|
SHL News
Last Important Events
Siemens Healthineers AG
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Siemens Healthineers AG
Company Profile
Siemens Healthineers AG
Country
Industry
Market Cap
Dividend Yield
Description
Siemens Healthineers AG operates as a holding company. The company is headquartered in Erlangen, Bayern and currently employs 66,800 full-time employees. The company went IPO on 2018-03-16. The firm offers a wide range of products and services in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine. The company provides medical technology and software solutions, as well as clinical consulting services. Additionally, the Company develops its digital health and enterprise services trough expanding precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare. The firm is active worldwide.
Contact
IPO
Employees
Officers
The intrinsic value of one
SHL
stock under the Base Case scenario is
65.88
EUR.
Compared to the current market price of 50.8 EUR,
Siemens Healthineers AG
is
Undervalued by 23%.
You don't have any saved screeners yet
